An integrated TAXUS IV, V, and VI intravascular ultrasound analysis of the predictors of edge restenosis after bare metal or paclitaxel-eluting stents.

[1]  Theodore A Bass,et al.  Impact of stent deployment procedural factors on long-term effectiveness and safety of sirolimus-eluting stents (final results of the multicenter prospective STLLR trial). , 2008, The American journal of cardiology.

[2]  J. Popma,et al.  Clinical Efficacy of Polymer-Based Paclitaxel-Eluting Stents in the Treatment of Complex, Long Coronary Artery Lesions From a Multicenter, Randomized Trial: Support for the Use of Drug-Eluting Stents in Contemporary Clinical Practice , 2005, Circulation.

[3]  P. Fitzgerald,et al.  Predictors of edge stenosis following sirolimus-eluting stent deployment (a quantitative intravascular ultrasound analysis from the SIRIUS trial). , 2005, The American journal of cardiology.

[4]  Gregg W Stone,et al.  Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. , 2005, JAMA.

[5]  J. Moses,et al.  Quantitative Assessment of Angiographic Restenosis After Sirolimus-Eluting Stent Implantation in Native Coronary Arteries , 2004, Circulation.

[6]  J. Popma,et al.  The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). , 2004, Journal of the American College of Cardiology.

[7]  R. Whitbourn,et al.  Vascular Responses at Proximal and Distal Edges of Paclitaxel-Eluting Stents: Serial Intravascular Ultrasound Analysis From the TAXUS II Trial , 2004, Circulation.

[8]  G. Stone,et al.  A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. , 2004, The New England journal of medicine.

[9]  William Wijns,et al.  Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS) , 2003, The Lancet.

[10]  F. Burzotta,et al.  Stenting of Culprit Lesions in Unstable Angina Leads to a Marked Reduction in Plaque Burden: A Major Role of Plaque Embolization?: A Serial Intravascular Ultrasound Study , 2003, Circulation.

[11]  C. Macaya,et al.  Predictors and implications of residual plaque burden after coronary stenting: an intravascular ultrasound study. , 2003, American heart journal.

[12]  P. Serruys,et al.  A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. , 2002, The New England journal of medicine.

[13]  P. Levendag,et al.  Angiographical Follow-Up After Radioactive “Cold Ends” Stent Implantation: A Multicenter Trial , 2002, Circulation.

[14]  N. Weissman,et al.  Extent and distribution of in-stent intimal hyperplasia and edge effect in a non-radiation stent population. , 2001, The American journal of cardiology.

[15]  N. Weissman,et al.  Serial intravascular ultrasound analysis of edge recurrence after intracoronary gamma radiation treatment of native artery in-stent restenosis lesions. , 2001, The American journal of cardiology.

[16]  SuhridParikh,et al.  Edge Restenosis After Implantation of High Activity 32P Radioactive β-Emitting Stents , 2001 .

[17]  R. Mehran,et al.  Edge stenosis and geographical miss following intracoronary gamma radiation therapy for in-stent restenosis. , 2001, Journal of the American College of Cardiology.

[18]  A. Lansky,et al.  Mechanism of lumen enlargement during intracoronary stent implantation: an intravascular ultrasound study. , 2000, Circulation.

[19]  A. Colombo,et al.  Edge Restenosis After Implantation of High Activity 32P Radioactive β-Emitting Stents , 2000 .

[20]  P. Serruys,et al.  Effects of Intracoronary β-Radiation Therapy After Coronary Angioplasty An Intravascular Ultrasound Study , 1999 .

[21]  M. Leon,et al.  Serial intravascular ultrasound predictors of restenosis at the margins of Palmaz-Schatz stents. , 1997, The American journal of cardiology.

[22]  E. Regar,et al.  Serial follow-up after optimized ultrasound-guided deployment of Palmaz-Schatz stents. In-stent neointimal proliferation without significant reference segment response. , 1997, Circulation.